Skip to main content

Table 1 Laboratory test results. Elevated level is indicated by bold and decreased level is indicated by underline

From: The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report

Tests

 

Normal range

24-Jan

25-Jan

26-Jan

27-Jan

28-Jan

29-Jan

30-Jan

31-Jan

1-Feb

2-Feb

7-Feb

12-Feb

Routine Blood Tests

white blood cell count (109/L)

3.5–9.5

5.61

4.59

9.89

9.48

7.41

7.02

5.12

3.63

Neutrophil ratio (%)

40–75

80.4

73.1

87.4

88.3

80.1

78.2

75.7

54.2

Lymphocyte ratio (%)

20–50

14.8

18.7

7.9

7.1

11.3

13.4

13.5

32.8

Eosinophil ratio (%)

0.4–8

0.5

0.2

0

0

0

0.3

1

2.5

T cell ratio (%)

65–79

 

49.1

66

T cell absolute count (/μl)

  

337

920

Th-cell absoluet count(/μl)

  

223

534

Ts-cell absolute count(/μl)

  

110

379

Th/Ts ratio

0.9–3.6

 

2.03

1.41

Red blood cell

(1012/L)

4.3–5.8

5.05

4.94

4.8

4.53

4.86

4.86

4.53

4.14

Hemoglobin (g/L)

130–175

158

155

151

141

151

157

142

129

Platelet (109/L)

125–350

207

257

324

283

329

286

179

127

Biochemical tests

Albumin (ALB) (g/L)

35–50

39.7

39.5

40.3

38.9

37.9

41.7

40.7

Total Bilirubin (TB) (μmol/L)

1.7–21

19

17.2

13.7

19.1

14.1

8.2

21.9

Direct Bilirubin (DB) (μmol/L)

0.3–6.8

0

7.8

6.2

6.9

5.3

3.2

10.6

Alanine aminotransferase (ALT) (U/L)

21–72

65.2

51

173

265

242

134

46

Aspartate aminotransferase (AST) (U/L)

17–59

59

30

62

64

53

31

27

Alkaline phosphatase (ALP) (U/L)

45–125

231

172

123

95

97

96

77

γ-glutamyl transpeptadase  (GGT) (U/L)

0–49

508

473

371

277

230

135

104

Lactate dehydrogenase (LDH) (U/L)

313–618

770

 

257

206

201

195

151

Blood urea nitrogen (BUN) (mmol/L)

3.2–7.1

4.34

5.38

5.17

4.29

1.2

1.66

creatinine (Cr) (μmol/L)

57–97

61.8

55

61

66

66

57

cystatin c (Cys-C) (mg/L)

0–1.21

0.7

1.17

0.91

0.65

0.5

B2 microglobulin (Β2-M) (mg/L)

1.0–3.0

1.46

0.73

1.52

2.27

2.02

Procalcitonin (PCT) (ng/mL)

< 0.1

0.053

0.05

0.047

0.039

0.021

0.044

0.068

0.103

0.034

C-reactive protein (CRP) (mg/L)

< 10

177

48.73

19.37

9.23

4.94

3.11

7.43

11.24

3.93

Creatine kinase (CK) (U/L)

55–170

67

 

Creatine kinase-MB (CK-MB) (ng/mL)

0–2.37

< 0.22

0.76

0.84

Myoglobin (MYO) (ng/mL)

0–110

78.3

103.63

25.36

Cardiac Troponin I (CTnI) (ng/mL)

< 0.04

< 0.012

< 0.006

< 0.006

type B natriuretic peptide (BNP) (pmol/L)

0–23.1

34.1

 

 

Interleukin-6 (IL6) (pg/mL)

0–7

16.19

 

< 1.5

Blood gas assay

PH

7.35–7.45

7.428

7.448

7.452

7.447

7.445

7.457

7.432

7.454

7.429

7.414

7.395

7.392

PCO2 (mmHg)

35–45

43

39.1

39.1

39.2

39.7

39

41.8

38.8

41.5

43.3

45.6

45.6

PO2 (mmHg)

75–110

64.4

137

137

101

113

74.2

71.3

87.1

75.7

83.8

92.5

104

Actual sodium bicarbonate (mmol/L)

21.4–27.3

28.4

27

27.2

27

27.3

27.5

27.9

27.2

27.5

27.7

27.9

27.7

Whole blood alkali surplus (mmol/L)

−3-3

3.4

2.8

3.2

2.8

3

3.5

3.6

3.3

3.1

2.6

3

2.5

Oxygenation index

400–500

157

304

304

259

323

195

188

194

261

399

319

359

Lactate (mmol/L)

0.5–1.6

1.4

1.5

1.3

1.8

1.3

1.6

1

1.2

1.3

1.5

2.4

2

Fractional concentration of inspired oxygen (FiO2) (%)

15.0–100

41

45

45

39

35

38

38

45

29

21

29

29

Blood coagulation function tests

Prothrombin time activity (PTA) (%)

70–120

107

98

136

Prothrombin time (PT) (Sec)

11–15.1

12.7

13.2

11.5

Prothrombin time International normalizaed ration (PT INR)

0.75–1.25

0.96

1.01

0.85

Activated partial thromboplastin time (APTT) (Sec)

28–43.5

31.8

30

28.3

Antithrombin III (AT III) (%)

85–135

100

105

117

Fibrinogen (FIB) (g/L)

2–4

7.79

5.37

4.62

D-Dimer (Diffused intravascular coagulation, D-DIC) (μg/mL)

0–0.5

0.95

0.49

0.29